Integrum receives MDR certificate for the OPRA Implant System
Mölndal, Sweden, March 2[nd], 2023 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announced that the company has received an EU Medical Device Regulation (MDR) certificate for the OPRA[TM] Implant System. With this, the company is provided continued freedom of operation to commercialize its products within the EU.“We are happy to have passed the strict validation process to receive an MDR certificate. Based on this accomplishment, we can direct our sole focus on the commercial success of the OPRA[TM] Implant System through increased marketing activities and continued